Holzer Holzer & Fistel, LLC Announces Investigation into the Proposed Buyout of HealthSpring, Inc.

ATLANTA--(BUSINESS WIRE)--Holzer Holzer & Fistel, LLC is investigating whether the directors of HealthSpring, Inc. (“HealthSpring” or the “Company”) (NYSE: HS) complied with their fiduciary duties in approving the proposed acquisition of the Company by Cigna Corporation. According to the Company’s announcement, if the deal closes HeathSpring shareholders will receive $55.00 per share of HS owned. The investigation seeks to determine, among other things, whether the consideration to be paid to HealthSpring shareholders is fair and adequate.